Navigation Links
Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP,,Rheumatoid Arthritis and Lymphoma

ion with methotrexate. In preclinical studies, Rigel's R788 was shown to diminish the swelling and tissue destruction associated with RA. In addition, in a murine model of ITP, R788 was shown to increase platelet counts significantly.

Lymphoma is a large class of blood cancers that affect the lymphoid system, which is part of the immune system. In 2006, lymphoma affected an estimated 500,000 people in the United States, with 332,000 of them suffering from non-Hodgkin's varieties of the disease. Diffuse large B-cell lymphoma is the most common type of non-Hodgkin's lymphoma and is generally categorized as aggressive, marked by rapidly growing tumors in the lymph nodes, spleen, liver, bone marrow and other organs.

A variety of treatment options exist, including chemotherapy and radiation, but the five-year survival rate for non-Hodgkin's lymphoma patients is estimated to be around 50%. Even for those who respond to treatment, recurrence of the disease is common.

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases and cancer, as well as viral and metabolic diseases. Our goal is to file one new investigational new drug (IND) application in a significant indication each year. Rigel has achieved this goal every year since 2002. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

This press release contains "forward-looking" statements, including statements related to Rigel's plans to pursue clinical development of product candidates, the timing of results thereof and the potentia
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Rigel to Present New Research Programs at AACR Meeting
2. Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV Activity
3. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
4. XTL Provides Update on Phase I Clinical Trial of XTL-2125
5. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
6. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
7. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
8. NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
9. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
10. New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy
11. Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
Post Your Comments:
(Date:5/6/2015)... Delcath Systems, Inc. (NASDAQ: DCTH ), a specialty ... an emphasis on the treatment of primary and metastatic ... ended March 31, 2015.  Highlights of ... Achieved quarterly product revenue of $0.44 million, an increase ... of 2014; , Activated a prospective patient registry ...
(Date:5/6/2015)... Md. , May 6, 2015 The ... that it has finalized agreement with Richard M. ... 2021. "We are very pleased to have ... CEO," said Hal Baseman , the Chair of ... significant success, performance and growth.  Richard has led a ...
(Date:5/6/2015)... , May 06, 2015 Research and ... the addition of the "Global Suture Industry ... The Global Suture Industry Report 2015 is ... state of the suture industry. The ... including definitions, classifications, applications and industry chain structure. ...
Breaking Medicine Technology:Delcath Reports 2015 First Quarter Financial Results 2Delcath Reports 2015 First Quarter Financial Results 3Delcath Reports 2015 First Quarter Financial Results 4Delcath Reports 2015 First Quarter Financial Results 5Delcath Reports 2015 First Quarter Financial Results 6Delcath Reports 2015 First Quarter Financial Results 7Delcath Reports 2015 First Quarter Financial Results 8PDA Extends Richard M. Johnson as President/CEO for Six Additional Years 2Global Suture Industry Report 2015 - Forecast Trends to 2021 2Global Suture Industry Report 2015 - Forecast Trends to 2021 3
... Biodel Inc. (Nasdaq: BIOD ) announced today the ... Officer.  Dr. Steiner is a co-founder of Biodel and will ... served as Biodel,s chairman, president and chief executive officer from ... Errol De Souza was named the company,s president and chief ...
... YORK, Dec. 14, 2010 Reportlinker.com announces ... available in its catalogue: ... & Ablation Devices 2011 ... 2010, the Asia Pacific markets for cardiac ...
Cached Medicine Technology:Biodel Announces Retirement of Dr. Solomon Steiner as Chief Scientific Officer 2Biodel Announces Retirement of Dr. Solomon Steiner as Chief Scientific Officer 3Biodel Announces Retirement of Dr. Solomon Steiner as Chief Scientific Officer 4Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 2Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 3Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 4Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 5Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 6Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 7Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 8Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 9Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 10Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 11Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 12Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 13Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 14Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 15Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 16Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 17Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 18Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 19Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 20Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 21
(Date:5/6/2015)... Imprivata ® (NYSE: IMPR), the healthcare ... will lead a discussion about the Internet of Things ... authentication challenges, during Citrix Synergy (May 12-14, ... the benefits of creating a network of IP-connected computers, ... can share information. It will also emphasize the importance ...
(Date:5/6/2015)... Experienced Vancouver air conditioning installation and repair ... will now conduct their cooling services, including air conditioning ... commercial and residential units. Strata complex air conditioning services ... technical knowledge as well as a professionally trained staff. ... take away any old air conditioning unit to be ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Baptist ... are the first in north Florida and southeast ... is the latest innovation in total hip replacement ... advanced, surgeon-controlled robotic arm that enables the accurate ... Center Jacksonville has offered MAKOplasty® partial knee resurfacing ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Is Colorado’s ... , Next month the Centennial State will mark the ... cannabis sales to adults. And while Colorado’s legal marijuana ... during that time, it’s also facing some new challenges. ... are currently facing shortages, especially in the wake of ...
(Date:5/6/2015)... Vancouver Chiropractic Clinic, Backs in ... blog containing the Canadian Physical Activity and Sedentary ... for Exercise Physiology (CSEP). Since the CSEP is ... fitness research and personal training in Canada, its ... beneficial and a rich resource for many people. ...
Breaking Medicine News(10 mins):Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 3Health News:Vancouver Chiropractor Shares Canadian Physical Activity and Sedentary Behavior Guidelines by CSEP in New Blog 2
... ... emergency medical cache of disposable medical supplies, ready for quick use by patients and ... (PRWEB) ... of preparing for the possibility of a large scale health emergencies. Healthcare organizations need ...
... ... on the addictive nature of junk food along with the facts coming out through books ... ALL ONE supplements, has taken a public stand for good nutrition and a healthy diet. ... & Brian Show," out of Los Angeles. , ...
... ... in - with the apps Rx for a busy life. ,Life gets ... of popular mobile applications for iPhone, iPod touch, and the new IPad ... will make your busy life less stressful, less complicated and yes… more ...
... ... ardent supporter of Primary Children’s, opened his heart and wallet and pledged over $11,000 ... ... Medical Center and KSL NewsRadio recently kicked off their 34th Annual Radiothon to raise ...
... Up to 200 people hit ... , ... 2010-- Up to 200 people hit by Cyclone Tomas in Fiji have been given emergency shelter ... the Vanua Levu and Lau Group islands last month, destroying homes and crops and prompting authorities ...
... ... 2010 that exposed large retailers selling used and returned underwear, Pampered Passions Fine Lingerie has ... , ... One of the Web’s most popular fine lingerie retailers, Pampered Passions Fine Lingerie , ...
Cached Medicine News:Health News:Provide Medical Surge Care with MasCache by DQE 2Health News:Is Our Junk Food Diet Killing America? 2Health News:Is Our Junk Food Diet Killing America? 3Health News:Is Our Junk Food Diet Killing America? 4Health News:Dr. Appz Launches Comprehensive Productivity App for iPhone 2Health News:Thomas E. Mower Makes Generous Donations To Primary Children's Medical Center 2Health News:Thomas E. Mower Makes Generous Donations To Primary Children's Medical Center 3Health News:ShelterBox Aid Sent to Cyclone-Hit Fiji 2Health News:Pampered Passions Fine Lingerie Starts Petition Against Retailers Selling Used Underwear and Lingerie 2
... OCUFLOX® ophthalmic solution is an ... your doctor may instruct you ... an eye infection caused by ... ulcers are the 2 types ...
...
ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% is indicated for lowering IOP in patients with open-angle galucoma or ocular hypertension....
ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.15% is medication in the form of an eye drop that is used to lower the pressure inside your eye(s), also referred to as intraocular pressu...
Medicine Products: